ヘルスケア分析試験サービス市場：サービス別、サンプルタイプ別、エンドユーザー別-2024-2030年の世界予測

ヘルスケア分析試験サービス市場規模は、2023年に48億8,000万米ドルと推定され、2024年には54億1,000万米ドルに達し、CAGR 11.34%で2030年には103億6,000万米ドルに達すると予測されています。

ヘルスケア分析試験サービス市場には、ヘルスケア製品の安全性、有効性、品質を確保するためのバイオ分析試験、臨床試験サービス、物理的特性評価、メソッドバリデーション、環境モニタリング、バッチリリース試験などが含まれます。ヘルスケア企業は、コスト削減とコアコンピタンスへの集中を図るため、試験サービスを専門機関に委託する傾向が強まっています。世界の厳しい規制の枠組みは、ヘルスケア製品の厳格な試験とバリデーションを要求しており、包括的な分析試験サービスの必要性を後押ししています。バイオ医薬品や医療機器の進歩は、これらの技術革新が安全性と有効性の基準を満たしていることを保証するために、高度な試験サービスを必要とします。しかし、複雑な規制コンプライアンスを理解することは煩雑であり、試験プロセスを遅らせる可能性があります。ヘルスケア分析試験には複雑な性質があるため、高度に熟練した専門家が必要であり、このような人材の不足は市場の成長にとって課題となる可能性があります。さらに、迅速な検査法の開拓は、ヘルスケア製品の開発期間を大幅に短縮し、市場拡大の機会を生み出す可能性があります。臨床試験や検査プロセスにおけるデータ分析にAIや機械学習などの技術を活用することで、効率性が向上し、市場成長の可能性が生まれます。

サービスヘルスケア分野における必須試験サービス、医薬品の品質と環境安全性の保護

バッチリリース試験には、医薬品やバイオテクノロジー製品に対して市場リリース前に実施される一連の試験が含まれます。バッチリリース試験は、すべてのバッチが同一性、純度、力価、安全性に関して指定された基準を満たしていることを保証する重要なステップです。バイオ分析試験サービスは、生物学的システムにおける薬物およびその代謝物の定量に不可欠です。バイオ分析試験サービスは、医薬品開発および規制当局への申請において極めて重要であり、特に製薬およびバイオテクノロジー製品開発の初期段階にある企業にとって価値があります。臨床試験サービスは、医薬品の有効性と安全性プロファイルを証明することを目的とした臨床研究開発に携わる企業にとって不可欠です。環境モニタリングは、潜在的な汚染を検出するために、生産および研究開発エリアの空気、水、表面を体系的にサンプリングします。環境モニタリングサービスは、適正製造基準（GMP）を遵守し、特に無菌製造環境において製品の完全性を守る企業にとって最も重要です。

エンドユーザー：ヘルスケアと医薬品開発における分析試験の重要な役割、安全性と効率性の確保

臨床研究機関（CRO）は、薬物動態/薬力学（PK/PD）分析、生物学的分析試験、臨床試験データ管理を最適化するための分析試験サービスを求めています。ヘルスケア分析試験サービスは、上市前の医薬品の有効性と安全性の検証に役立っています。医療機器メーカーは、生体適合性評価、無菌性試験、環境分析のための分析試験サービスを必要としています。ヘルスケア分析試験は、医療機器がヒトに安全に使用され、厳しい規制基準を満たしていることを保証するために極めて重要です。製薬・バイオ医薬品企業は、原料試験、プロセスバリデーション、製品安定性試験、微生物試験など、幅広い分析試験サービスを必要としています。ヘルスケア分析試験サービスは、医薬品が効果的で安全であり、国際的な規制ガイドラインに適合していることを保証するために不可欠です。

地域別の洞察

南北アメリカ、特に米国とカナダは、先進的なヘルスケアシステムと厳格な規制環境により、ヘルスケア分析試験サービスの重要な市場となっています。米国は医薬品・医療機器製造の最前線であり、政府のイニシアティブや民間資金に支えられ、研究開発への投資が着実に増加しています。EMEA（欧州・中東・アフリカ）地域は、分析試験サービスにとって多様な様相を呈しています。製薬・バイオテクノロジー部門が確立しているEU諸国は、厳格なEU規制ガイドラインに裏打ちされた分析試験サービスに対する高いニーズを示しています。中東は、この分野ではまだ新興ではあるが、ヘルスケア・インフラへの投資と研究開発への急成長を通じて成長を目の当たりにしています。広大な潜在力を持つアフリカは、ヘルスケアの質とアクセシビリティの向上を目指した国際的な投資とイニシアチブに後押しされ、ヘルスケア分析試験で徐々に前進しています。中国、日本、インドなどの急成長国を含むアジア太平洋地域は、ヘルスケア分析試験サービスにおいて急速な成長を示しています。アジア太平洋地域の顧客は、主に費用対効果、品質、タイムリーなサービスの必要性に駆られており、ヘルスケア・インフラへの投資の増加がAPAC地域の市場拡大をさらに後押ししています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはヘルスケア分析試験サービス市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ヘルスケア分析試験サービス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.ヘルスケア分析試験サービス市場の市場規模および予測は？

2.ヘルスケア分析試験サービス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.ヘルスケア分析試験サービス市場の技術動向と規制枠組みは？

4.ヘルスケア分析試験サービス市場における主要ベンダーの市場シェアは？

5.ヘルスケア分析試験サービス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケア分野における分析試験アウトソーシングの需要増加
    • バイオ医薬品と医療機器の継続的な進歩
    • ヘルスケア分野における公的および民間支出の増加
  • 抑制要因
    • 高度なスキルを持つ専門家の不足
  • 機会
    • AIや機械学習などの先進技術の統合
    • 迅速検査法と個別化医療アプローチの開発
  • 課題
    • 世界中で厳しい規制基準
• 市場セグメンテーション分析
  • サービス：ヘルスケア分野における必須の試験サービス、医薬品の品質と環境の安全性の確保
  • エンドユーザー：ヘルスヘルスケアと医薬品開発における分析試験の重要な役割、安全性と効率性の確保
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 ヘルスケア分析試験サービス市場：サービス別

• バッチリリーステストサービス
• 生体分析試験
• 臨床試験検査
• 環境モニタリング

第7章 ヘルスケア分析試験サービス市場サンプルタイプ別

• 生物学的サンプル
• 化学物質

第8章 ヘルスケア分析試験サービス市場：エンドユーザー別

• 臨床調査機関
• 医療機器企業
• 製薬・バイオ医薬品企業

第9章 南北アメリカのヘルスケア分析試験サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のヘルスケア分析試験サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのヘルスケア分析試験サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • LGM Pharmaによる分析試験および製造能力の強化
  • Kindevaドラッグデリバリーが分析サービスを強化し、医薬品および医療機器分野における世界な能力を向上
  • ミリポアシグマがライフサイエンスの品質試験に革命を起こすChemisTwinを発売
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DYNAMICS
• FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BATCH RELEASE TESTING SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BATCH RELEASE TESTING SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL TRIALS TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL TRIALS TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICAL SAMPLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICAL SAMPLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL SUBSTANCES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL SUBSTANCES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 51. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 52. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 53. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 54. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 55. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 56. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 85. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 86. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 87. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 88. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 89. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 90. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 91. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 92. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 93. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 94. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 95. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 96. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 195. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 196. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 197. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 198. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 199. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 200. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 219. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 220. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 221. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 222. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 223. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 224. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 225. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 226. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 227. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 228. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 229. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 230. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 285. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

[192 Pages Report] The Healthcare Analytical Testing Services Market size was estimated at USD 4.88 billion in 2023 and expected to reach USD 5.41 billion in 2024, at a CAGR 11.34% to reach USD 10.36 billion by 2030.

The healthcare analytical testing services market includes bioanalytical testing, clinical trial services, physical characterization, method validation, environmental monitoring, and batch-release testing to ensure the safety, efficacy, and quality of healthcare products. Healthcare companies increasingly prefer to outsource testing services to specialized organizations to reduce costs and focus on their core competencies. Strict regulatory frameworks worldwide demand rigorous testing and validation of healthcare products, propelling the need for comprehensive analytical testing services. Advances in biopharmaceuticals and medical devices necessitate sophisticated testing services to ensure these innovations meet safety and efficacy standards. However, navigating complexities of regulatory compliance can be cumbersome and slow down the testing process. The intricate nature of healthcare analytical testing demands highly skilled professionals, and a shortage in this workforce may be challenging for market growth. Moreover, the development of rapid testing methods may drastically reduce development timelines for healthcare products, creating opportunities for market expansion. Leveraging technologies, including AI and machine learning for data analysis in clinical trials and testing processes, can enhance efficiency, generating growth potential in the market space.

Services: Essential Testing Services in Healthcare Sector, Safeguarding Drug Quality and Environmental Safety

Batch release testing involves a series of tests conducted on pharmaceutical and biotechnological products prior to the market release. Batch release testing is a crucial step, ensuring that every batch meets the specified standards for identity, purity, potency, and safety. Bioanalytical testing services are essential for the quantification of drugs and their metabolites in biological systems. Bioanalytical testing service is crucial for drug development and regulatory submission, particularly valuable for companies in the early stages of pharmaceutical and biotech product development. Clinical trial testing services are essential for entities involved in clinical research and development, aiming to prove efficacy and safety profile of the drug products. Environmental monitoring involves systematically sampling air, water, and surfaces in the production and laboratory areas to detect potential contamination. Environmental monitoring service is paramount for companies that comply with Good Manufacturing Practices (GMP) and protect product integrity, particularly in sterile manufacturing environments.

End User: Crucial Role of Analytical Testing in Healthcare and Pharmaceutical Development, Ensuring Safety and Efficiency

Clinical Research Organizations (CROs) demand analytical testing services to optimize pharmacokinetic/pharmacodynamic (PK/PD) analysis, bioanalytical testing, and clinical trial data management. Healthcare analytical testing services are instrumental for the validation of drug efficacy and safety before market release. Medical device companies require analytical testing services for biocompatibility assessment, sterility testing, and environmental analysis. Healthcare analytical testing is pivotal for ensuring that medical devices are safe for human use and meet stringent regulatory standards. Pharmaceutical & biopharmaceutical companies require a broad spectrum of analytical testing services, such as raw material testing, process validation, product stability testing, and microbiological testing. Healthcare analytical testing services are critical for ensuring that pharmaceutical products are effective, safe, and in conformity with international regulatory guidelines.

Regional Insights

The Americas, particularly the United States and Canada, represent a significant market for healthcare analytical testing services owing to their advanced healthcare systems and stringent regulatory environment. The United States, being at the forefront in pharmaceutical and medical device manufacturing, has seen a steady influx of investments in R&D, supported by government initiatives and private funding. The EMEA region presents a diverse landscape for analytical testing services. EU countries, with their well-established pharmaceutical and biotechnology sectors, demonstrate a high need for analytical testing services underscored by rigorous EU regulatory guidelines. The Middle East, though still emerging in this sector, is witnessing growth through investments in healthcare infrastructure and a burgeoning focus on research and development. Africa, with its vast potential, is gradually advancing in healthcare analytical testing, buoyed by international investments and initiatives aimed at improving healthcare quality and accessibility. The Asia Pacific region, including burgeoning countries such as China, Japan, and India, has demonstrated rapid growth in healthcare analytical testing services. Customers in the Asia Pacific are primarily driven by the need for cost-effectiveness, quality, and timely services, and rising investments in healthcare infrastructure further propel market expansion in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Healthcare Analytical Testing Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Healthcare Analytical Testing Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Analytical Testing Services Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, ALS Limited, Catalent, Inc., CD Biosciences Inc., Charles River Laboratories, Inc., Element Materials Technology Group Limited, Eurofins Scientific SE, Frontage Laboratories, Inc. by Tigermed, ICON PLC, Intertek Group PLC, IQVIA, Inc., Laboratory Corporation of America Holdings, Medpace, Inc., Merck KGaA, Pace Analytical Services, LLC, Piramal Pharma Solutions, PPD, Inc., Reading Scientific Services Ltd., Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Analytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Services
  • Batch Release Testing Services
  • Bioanalytical Testing
  • Clinical Trials Testing
  • Environmental Monitoring

• Sample Type
  • Biological Samples
  • Chemical Substances

• End User
  • Clinical Research Organizations
  • Medical Device Companies
  • Pharmaceutical & Biopharmaceutical Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Healthcare Analytical Testing Services Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Healthcare Analytical Testing Services Market?

3. What are the technology trends and regulatory frameworks in the Healthcare Analytical Testing Services Market?

4. What is the market share of the leading vendors in the Healthcare Analytical Testing Services Market?

5. Which modes and strategic moves are suitable for entering the Healthcare Analytical Testing Services Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for analytical testing outsourcing in healthcare sector
    • 5.1.1.2. Ongoing advances in biopharmaceuticals and medical devices
    • 5.1.1.3. Rising public and private expenditure in healthcare sector
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of highly skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of advanced technologies including AI and machine learning
    • 5.1.3.2. Development of rapid testing methods and personalized medicine approach
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory standards worldwide
• 5.2. Market Segmentation Analysis
  • 5.2.1. Services: Essential Testing Services in Healthcare Sector, Safeguarding Drug Quality and Environmental Safety
  • 5.2.2. End User: Crucial Role of Analytical Testing in Healthcare and Pharmaceutical Development, Ensuring Safety and Efficiency
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Healthcare Analytical Testing Services Market, by Services

• 6.1. Introduction
• 6.2. Batch Release Testing Services
• 6.3. Bioanalytical Testing
• 6.4. Clinical Trials Testing
• 6.5. Environmental Monitoring

7. Healthcare Analytical Testing Services Market, by Sample Type

• 7.1. Introduction
• 7.2. Biological Samples
• 7.3. Chemical Substances

8. Healthcare Analytical Testing Services Market, by End User

• 8.1. Introduction
• 8.2. Clinical Research Organizations
• 8.3. Medical Device Companies
• 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Healthcare Analytical Testing Services Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Healthcare Analytical Testing Services Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Healthcare Analytical Testing Services Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Enhancing Analytical Testing and Manufacturing Capabilities by LGM Pharma
  • 12.3.2. Kindeva Drug Delivery Bolsters Analytical Services, Enhancing Global Capabilities in Pharmaceutical and Medical Device Sectors
  • 12.3.3. Launch of ChemisTwin by MilliporeSigma, Revolutionizing Quality Testing in Life Sciences
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio